Compared to their St2+/+ and St2+/−-proficient compound mutant littermates, gp130FF; St2−/− mice harbored a significantly lower overall tumor burden at 100 days of age (Fig. 7a), which arose from reduced tumor growth rather than reduced tumor incidence (Fig. 7b). The gene discussed is IL1RL1; the disease is neoplasm.